UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35

Cell death and differentiation, 2008-12, Vol.15 (12), p.1815-1823

2008

Volltextzugriff (PDF)

p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050

2013

Volltextzugriff (PDF)

Nuclear translocation of IGF-1R by amphiregulin: a regulator of the response of lung adenocarcinoma to EGFR-TKI?

European journal of cancer (1990), 2016-07, Vol.61, p.S125-S125

2016

Volltextzugriff (PDF)

sVEGFR1, the VEGFR1 splice variant: A dual function in the response of squamous cell lung carcinoma to anti-angiogenic therapies

European journal of cancer (1990), 2016-07, Vol.61, p.S125-S125

2016

Volltextzugriff (PDF)

496: Nuclear EGFR controls the expression of the ARF tumor suppressor

European journal of cancer (1990), 2014-07, Vol.50, p.S119-S119

2014

Volltextzugriff (PDF)

322 The VEGF-a Splice Variants VEGF155 and VEGF155b Differentially Control the Proliferation of Non Small Cell Lung Carcinoma Cells

European journal of cancer (1990), 2012-07, Vol.48, p.S79-S79

2012

Volltextzugriff (PDF)

204: Pre-mRNA alternative splicing controls VEGF-A autocrine functions and response to bevacizumab in non small cell lung carcinoma

European journal of cancer (1990), 2014-07, Vol.50, p.S46-S47

2014

Volltextzugriff (PDF)

Cibler le splicéosome : une nouvelle stratégie thérapeutique pour contrecarrer la résistance à la chimiothérapie dans les cancers du poumon ?

Revue des maladies respiratoires, 2024-04, Vol.41 (4), p.294-298

2024

Volltextzugriff (PDF)

321 An EGFR/ARF Cross-talk Controls the Growth of Lung Adenocarcinoma Cells With Mutant EGFR

European journal of cancer (1990), 2012-07, Vol.48, p.S78-S79

2012

Volltextzugriff (PDF)

The yin and the yang of p27Kip1 as a target for cancer therapy

The European respiratory journal, 2004-05, Vol.23 (5), p.663-664

2004

Volltextzugriff (PDF)

SPHINX31, a SRPK1 inhibitor, regulates the ATR/DNA-PKcs/CHK1 replicative checkpoint to inhibit cell growth in NSCLC cells

Revue des maladies respiratoires, 2024-03, Vol.41 (3), p.194-195

2024

Volltextzugriff (PDF)

Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status

Oncogene, 2001-10, Vol.20 (45), p.6587

2001

Volltextzugriff (PDF)

The role of apoptosis in the pathogenesis and treatment of diseases

The European respiratory journal, 1996-06, Vol.9 (6), p.1293-1305

1996

Volltextzugriff (PDF)

Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein

Gene therapy, 2003-02, Vol.10 (4), p.314-325

2003

Volltextzugriff (PDF)

573 - Nuclear translocation of IGF-1R by amphiregulin: a regulator of the response of lung adenocarcinoma to EGFR-TKI?

European journal of cancer (1990), 2016-07, Vol.61, p.S125-S125

2016

Volltextzugriff (PDF)

Proteases, proteolysis, and apoptosis

Cell biology and toxicology, 1998-03, Vol.14 (2), p.121-132

1998

Volltextzugriff (PDF)

Human tumor suppressor p14 negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation

Oncogene, 2006-12, Vol.25 (58), p.7577-7586

2006

Volltextzugriff (PDF)

572 - sVEGFR1, the VEGFR1 splice variant: A dual function in the response of squamous cell lung carcinoma to anti-angiogenic therapies

European journal of cancer (1990), 2016-07, Vol.61, p.S125-S125

2016

Volltextzugriff (PDF)

p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050

2013

Volltextzugriff (PDF)

p14 super(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050-1058

2013

Volltextzugriff (PDF)

inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050

2013

Volltextzugriff (PDF)

Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors

Oncogene, 2002-04, Vol.21 (17), p.2750

2002

Volltextzugriff (PDF)

468 Role of the p14ARF tumour suppressor in EGFR-mediated growth control of lung cancer cells

European journal of cancer supplements, 2010, Vol.8 (5), p.120-120

2010

Volltextzugriff (PDF)

412 An acetylation/phosphorylation signalling network governs turn-over and activity of the splicing factor SC35 in response to cisplatin

European journal of cancer supplements, 2010, Vol.8 (5), p.105-106

2010

Volltextzugriff (PDF)

p14 induces G arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice

Oncogene, 2003-03, Vol.22 (12), p.1822-1835

2003

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(82)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Life Sciences
(12)
Hematology, Oncology And Palliative Medicine
(11)
Biological And Medical Sciences
(10)
Apoptosis
(9)
Biochemistry & Molecular Biology
(9)
Cell Biology
(9)
Cellular Biology
(9)
Cancer
(8)
Medical Sciences
(7)
Genetics & Heredity
(6)
Lung Neoplasms - Metabolism
(6)
Oncology
(6)
Apoptosis - Drug Effects
(5)
Lung Cancer
(5)
Antineoplastic Agents
(4)
Cell Cycle Proteins
(4)
General Aspects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35

p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Nuclear translocation of IGF-1R by amphiregulin: a regulator of the response of lung adenocarcinoma to EGFR-TKI?

sVEGFR1, the VEGFR1 splice variant: A dual function in the response of squamous cell lung carcinoma to anti-angiogenic therapies

496: Nuclear EGFR controls the expression of the ARF tumor suppressor

322 The VEGF-a Splice Variants VEGF155 and VEGF155b Differentially Control the Proliferation of Non Small Cell Lung Carcinoma Cells

204: Pre-mRNA alternative splicing controls VEGF-A autocrine functions and response to bevacizumab in non small cell lung carcinoma

Cibler le splicéosome : une nouvelle stratégie thérapeutique pour contrecarrer la résistance à la chimiothérapie dans les cancers du poumon ?

321 An EGFR/ARF Cross-talk Controls the Growth of Lung Adenocarcinoma Cells With Mutant EGFR

The yin and the yang of p27Kip1 as a target for cancer therapy

SPHINX31, a SRPK1 inhibitor, regulates the ATR/DNA-PKcs/CHK1 replicative checkpoint to inhibit cell growth in NSCLC cells

Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status

The role of apoptosis in the pathogenesis and treatment of diseases

Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein

573 - Nuclear translocation of IGF-1R by amphiregulin: a regulator of the response of lung adenocarcinoma to EGFR-TKI?

Proteases, proteolysis, and apoptosis

Human tumor suppressor p14 negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation

572 - sVEGFR1, the VEGFR1 splice variant: A dual function in the response of squamous cell lung carcinoma to anti-angiogenic therapies

p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

p14 super(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors

468 Role of the p14ARF tumour suppressor in EGFR-mediated growth control of lung cancer cells

412 An acetylation/phosphorylation signalling network governs turn-over and activity of the splicing factor SC35 in response to cisplatin

p14 induces G arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice

Aktive Filter

Suchergebnisse filtern